NCT00483483

Brief Summary

The objective of this study is to test in a randomized controlled trial the effectiveness of a US secondary HIV prevention program to reduce HIV risk behaviors, STD acquisition, and alcohol consumption among HIV-infected Russians with risky drinking.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
700

participants targeted

Target at P75+ for not_applicable hiv-infections

Timeline
Completed

Started Oct 2007

Longer than P75 for not_applicable hiv-infections

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 6, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 7, 2007

Completed
4 months until next milestone

Study Start

First participant enrolled

October 1, 2007

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2011

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2012

Completed
Last Updated

July 21, 2017

Status Verified

July 1, 2017

Enrollment Period

3.8 years

First QC Date

June 6, 2007

Last Update Submit

July 19, 2017

Conditions

Keywords

HIVUnsafe sexHigh-risk sexNeedle sharingSTDs

Outcome Measures

Primary Outcomes (1)

  • Number of unprotected sex acts, unclean drug injections, and sexually transmitted infections (by urinalysis)

    12 months

Secondary Outcomes (1)

  • Percentage of protected sex episodes, percentage of unprotected sex episodes Multiple drug partners, Number of sexually transmitted infections (by self report), Alcohol consumption, Disclosure of HIV serostatus

    12 months

Study Arms (2)

1

EXPERIMENTAL

Healthy Relationships Intervention (HRI)

Behavioral: Individual and group HIV risk behavior counseling sessions

Attention-control group

ACTIVE COMPARATOR

health education \& support

Behavioral: health education and support group

Interventions

Healthy Relationships Intervention (HRI) culturally adapted and modified to address substance use and associated risk behaviors; subjects will attend three 2-hour structured group sessions in addition to two 1-hour individualized sessions over the course of 10 days.

Also known as: HRI
1

general health information (nutrition, stress reduction) in 2 individual sessions and 3 group sessions.

Attention-control group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-70 years old;
  • HIV positive;
  • Alcohol consumption at NIAAA at-risk drinking levels (greater than 14 drinks per week \[or more than 4 drinks per day\] for men, and greater than 7 drinks per week \[or more than 3 drinks per day\] for women) during the 30 days prior to hospital admission, For subjects whose drinking was not risky 30 days prior to hospital admission, we will ask if their drinking was equivalent to binge amounts on any day in the prior 6 months;
  • Self-reported unprotected anal or vaginal sex in the last 6 months;
  • Provision of contact information (e.g., name, home address, telephone number) of two relatives or close friends who can be contacted to share information that may be used to assist with follow-up;
  • Stable address within St. Petersburg or districts within 150 kilometers of St. Petersburg; and
  • Possession of a home telephone;
  • Fluent in Russian;
  • Ability to provide informed consent.

You may not qualify if:

  • Severe cognitive impairment (i.e., clinically apparent dementia, active psychosis, or severe paranoid disorder) as judged by a hospital clinician and stated in the records;
  • Acute illness precluding ability to participate in assessment for eligibility (however these patients may be assessed again on a subsequent day);
  • Trying to get (partner) pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

City Drug Addiction Center

Saint Petersburg, Russia

Location

Pavlov State Medical University and Botkin Infectious Disease Hospital

Saint Petersburg, Russia

Location

St. Petersburg AIDS Center

Saint Petersburg, Russia

Location

Related Publications (4)

  • Greene MC, Kane J, Alto M, Giusto A, Lovero K, Stockton M, McClendon J, Nicholson T, Wainberg ML, Johnson RM, Tol WA. Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries. Cochrane Database Syst Rev. 2023 May 9;5(5):CD013350. doi: 10.1002/14651858.CD013350.pub2.

  • Samet JH, Blokhina E, Cheng DM, Walley AY, Lioznov D, Gnatienko N, Quinn EK, Bridden C, Chaisson CE, Toussova O, Gifford AL, Raj A, Krupitsky E. A strengths-based case management intervention to link HIV-positive people who inject drugs in Russia to HIV care. AIDS. 2019 Jul 15;33(9):1467-1476. doi: 10.1097/QAD.0000000000002230.

  • Lunze K, Lioznov D, Cheng DM, Nikitin RV, Coleman SM, Bridden C, Blokhina E, Krupitsky E, Samet JH. HIV Stigma and Unhealthy Alcohol Use Among People Living with HIV in Russia. AIDS Behav. 2017 Sep;21(9):2609-2617. doi: 10.1007/s10461-017-1820-8.

  • Samet JH, Raj A, Cheng DM, Blokhina E, Bridden C, Chaisson CE, Walley AY, Palfai TP, Quinn EK, Zvartau E, Lioznov D, Krupitsky E. HERMITAGE--a randomized controlled trial to reduce sexually transmitted infections and HIV risk behaviors among HIV-infected Russian drinkers. Addiction. 2015 Jan;110(1):80-90. doi: 10.1111/add.12716. Epub 2014 Oct 16.

MeSH Terms

Conditions

HIV InfectionsUnsafe SexSexually Transmitted Diseases

Interventions

Self-Help Groups

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesSexual BehaviorBehaviorDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

OrganizationsHealth Care Economics and Organizations

Study Officials

  • Jeffrey H. Samet, MD, MA, MPH

    Boston Medical Center, Boston University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Section of General Internal Medicine

Study Record Dates

First Submitted

June 6, 2007

First Posted

June 7, 2007

Study Start

October 1, 2007

Primary Completion

July 1, 2011

Study Completion

March 1, 2012

Last Updated

July 21, 2017

Record last verified: 2017-07

Locations